FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure
Open accessThe DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Abstract
Environmental factors such as nutritional state may act on the epigenome that consequently contributes to the metabolic adaptation of cells and the organisms. The lysine-specific demethylase-1 (LSD1) is a unique nuclear protein that utilizes flavin adenosine dinucleotide (FAD) as a cofactor. Here we show that LSD1 epigenetically regulates energy-expenditure genes in adipocytes depending on the cellular FAD availability. We find that the loss of LSD1 function, either by short interfering RNA or by selective inhibitors in adipocytes, induces a number of regulators of energy expenditure and mitochondrial metabolism such as PPARγ coactivator-1α resulting in the activation of mitochondrial respiration. In the adipose tissues from mice on a high-fat diet, expression of LSD1-target genes is reduced, compared with that in tissues from mice on a normal diet, which can be reverted by suppressing LSD1 function. Our data suggest a novel mechanism where LSD1 regulates cellular energy balance through coupling with cellular FAD biosynthesis. Lysine-specific demethylase 1 (LSD1) removes methyl groups from mono-methylated and dimethylated lysine 4 of histone H3 and represses transcription. In this study, a role for LSD1 in the regulation of genes involved in energy expenditure in adipocytes is reportedin vitroand in mice fed on a high-fat diet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Specifically, LSD1 binds directly to genes such as PPARg coactivator-1α (PGC1α), PDK4, FATP1, and ATGL and represses their transcription associated with loss of H3K4 methylation (Hino et al., 2012).”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Hino et al., 2012
In the citing paper
“LSD1, in turn, regulates mitochondrial respiration and energy expenditure.”
From Influence of Metabolism on Epigenetics and Disease (2013) · cites this paper as Hino et al., 2012
In the citing paper
“Sensitive to changes in NAD+ or FAD availability, these enzymes orchestrate global post-translational and epigenetic changes that promote energy conservation (Hino et al., 2012; Schwer and Verdin, 2008).”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Hino et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gatta, R. P., & Mantovani, R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn699 · Cited by 41
RetractedSubramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
Metzger, E., Wissmann, M., Yin, N., Müller, J. M., Schneider, R., Peters, A. H. F. M., Günther, T., Buettner, R., & Schüle, R. (2005) · Nature · doi:10.1038/nature04020 · Cited by 1,733
Developmental Origin of Fat: Tracking Obesity to Its Source
Gesta, S., Tseng, Y.-H., & Kahn, C. R. (2007) · Cell · doi:10.1016/j.cell.2007.10.004 · Cited by 1,508
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D., & Tipton, K. F. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1883 · Cited by 1,363
Felsenfeld, G., & Groudine, M. (2003) · Nature · doi:10.1038/nature01411 · Cited by 1,150
Cited by
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Influence of Metabolism on Epigenetics and Disease
Kaelin, W. G., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.03.004 · Cited by 920
“It has been suggested that the nuclear location of LSD1 might render it particularly sensitive to changes in FAD availability (and the ratio of FAD to FADH2) arising from the activities of other flavin-linked dehydrogenases and oxidases, including those associated with fatty acid b-oxidation and the TCA cycle (Hino et…”
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
“Mitochondria also regulate the levels and redox state of FAD, a cofactor of the histone demethylase LSD1.(175) Dysfunctional mitochondria can be removed by mitophagy, which is also very important in the progression of AD.”
BackgroundPGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
“Lack of flavin adenosine dinucleotide, an essential cofactor in fatty acid oxidation (FAO), downregulates LSD1 and promotes PGC-1α expression [26].”
BackgroundInterplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes
Etchegaray, J.-P., & Mostoslavsky, R. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.029 · Cited by 518
“Both LSD1 and LSD2 use FAD as cofactor (Forneris et al., 2005).”
BackgroundInfluentialMitochondria and Epigenetics – Crosstalk in Homeostasis and Stress
Matilainen, O., Quirós, P. M., & Auwerx, J. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.02.004 · Cited by 364
Metabolic Regulation of Histone Post-Translational Modifications
Fan, J., Krautkramer, K. A., Feldman, J. L., & Denu, J. M. (2015) · ACS Chemical Biology · doi:10.1021/cb500846u · Cited by 330
“Highlighting the correlation between histone methylation and energy metabolism, a recent study in 3T3-L1 cells showed that histone demethylation by LSD1 regulates energyexpenditure genes, inhibition of LSD1 increases cell oxidation rate (97).”
BackgroundMetabolic Reprogramming of Stem Cell Epigenetics
Ryall, J. G., Cliff, T., Dalton, S., & Sartorelli, V. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.11.012 · Cited by 328
Epigenetics and Trained Immunity
van der Heijden, C. D. C. C., Noz, M. P., Joosten, L. A. B., Netea, M. G., Riksen, N. P., & Keating, S. T. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7310 · Cited by 278
“Importantly, this modification is reversed by lysine-specific histone demethylase 1 (LSD1) (64), an epigenetic enzyme that is influenced by cellular levels of flavin adenosine di-nucleotide and is, therefore, sensitive to metabolic variation (44).”
Li, L., & Li, W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.004 · Cited by 254
“Specifically, LSD1 binds directly to genes such as PPARγ coactivator-1a (PGC1a) and represses their transcription through H3K4 demethylation, resulting in the inhibition of mitochondrial respiration (Hino et al., 2012).”
BackgroundLSD1: more than demethylation of histone lysine residues
Perillo, B., Tramontano, A., Pezone, A., & Migliaccio, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00542-2 · Cited by 214
LSD1: Biologic Roles and Therapeutic Targeting
Maiques-Diaz, A., & Somervaille, T. C. (2016) · Epigenomics · doi:10.2217/epi-2016-0009 · Cited by 204
Riboflavin transport and metabolism in humans
Barile, M., Giancaspero, T. A., Leone, P., Galluccio, M., & Indiveri, C. (2016) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-016-9950-0 · Cited by 199
“…methionine; MTRR: methionine synthase reductase; MTHFR: methylenetetrahydrofolate reductase; FH4: tetrahydrofolate the nucleus, FAD dependent oxidases play some roles in epigenetic events, controlling the expression of genes involved in energy metabolism (Hino et al 2012; Giancaspero et al 2013a).”
BackgroundMethodThe winding path of protein methylation research: milestones and new frontiers
Murn, J., & Shi, Y. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.35 · Cited by 195
An Overview of Epigenetics in Obesity: The Role of Lifestyle and Therapeutic Interventions
Mahmoud, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031341 · Cited by 189
A Systematic Review of Histone Lysine‐Specific Demethylase 1 and Its Inhibitors
Zheng, Y., Ma, J., Wang, Z., Li, J., Jiang, B., Zhou, W., Shi, X., Wang, X., Zhao, W., & Liu, H. (2015) · Medicinal Research Reviews · doi:10.1002/med.21350 · Cited by 186
Antioxidant dietary approach in treatment of fatty liver: New insights and updates
Ferramosca, A., Di Giacomo, M., & Zara, V. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i23.4146 · Cited by 180
Metabolic Inputs into the Epigenome
Sharma, U., & Rando, O. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.02.003 · Cited by 167
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trials
Noce, B., Bello, E. D., Fioravanti, R., & Mai, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1120911 · Cited by 166
“Finally, LSD1 has been reported to be involved in metabolic diseases (Hino et al., 2012) and in central nervous system disorders, such as Alzheimer’s disease and depression (Rusconi et al.”
BackgroundA Comprehensive Review of Lysine-Specific Demethylase 1 and its Roles in Cancer
Hosseini, A., & Minucci, S. (2017) · Epigenomics · doi:10.2217/epi-2017-0022 · Cited by 138
Cancer metabolism and tumor microenvironment: fostering each other?
Yuan, Y., Li, H., Wang, P., Chen, L., Guo, D. S., Jiang, H., He, B., Qin, S., Wang, K., Li, N., et al. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1999-2 · Cited by 144
“From the eraser side, NAD+ facilitates the removal of PTMs that are amide-bonded to lysine, while FAD+ acts as a cofactor for lysine-specific demethylase LSD1 (Hino et al., 2012; Schwer and Verdin, 2008). α-KG has received significant attention in tumorigenesis as it reportedly affects a family of α-KG-dependent dioxy…”
BackgroundCardamone, M. D., Tanasa, B., Cederquist, C. T., Huang, J., Mahdaviani, K., Li, W., Rosenfeld, M. G., Liesa, M., & Perissi, V. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.037 · Cited by 132
“In mammalian cells, demethylation is partially achieved, but not limited to the action of the histone demethylase JMJD2/KDM4A, suggesting thatother demethylases might be important for providing specificity to the regulation of different gene subsets and contribute to the fine-tuning of the stress response (Duteil et a…”
LSD1 promotes oxidative metabolism of white adipose tissue
Duteil, D., Metzger, E., Willmann, D., Karagianni, P., Friedrichs, N., Greschik, H., Günther, T., Buettner, R., Talianidis, I., METZGER, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5093 · Cited by 138
Two genomes, one cell: Mitochondrial-nuclear coordination via epigenetic pathways
Wiese, M., & Bannister, A. J. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.006 · Cited by 112
“com riboflavin kinase or FADS in adipocytes inhibits LSD1 activity, resulting in increased H3K4 methylation, allowing master regulator PGC-1a to activate the expression of genes related to energy expenditure and ultimately mitochondrial respiration and induction of lipolysis [86].”
BackgroundSakamoto, A., Hino, S., Nagaoka, K., Anan, K., Takase, R., Matsumori, H., Ojima, H., Kanai, Y., Arita, K., & Nakao, M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1560 · Cited by 107
Self-citationMetabolism and the Epigenome: A Dynamic Relationship
Haws, S. A., Leech, C. M., & Denu, J. M. (2020) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2020.04.002 · Cited by 115
Salminen, A., Haapasalo, A., Kauppinen, A., Kaarniranta, K., Soininen, H. S., & Hiltunen, M. O. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.001 · Cited by 112
“Hino et al. (2012) revealed that the activation of LSD1 repressed the expression of several energy metabolic regulators, e.g. PPARg coactivator-1a (PGC-1a), whereas the loss of LSD1 induced their expression and stimulated mitochondrial metabolism in adipocytes.”
BackgroundLSD1 mediates microbial metabolite butyrate-induced thermogenesis in brown and white adipose tissue
Wang, D., Liu, C.-D., Li, H., Tian, M.-L., Pan, J., Shu, G., Jiang, Q., Yin, Y., & Zhang, L. (2019) · Metabolism · doi:10.1016/j.metabol.2019.154011 · Cited by 109
Cui, S., Lim, K.-C., Shi, L., Lee, M., Jearawiriyapaisarn, N., Myers, G., Campbell, A., Harro, D., Iwase, S., Trievel, R. C., et al. (2015) · Blood · doi:10.1182/blood-2015-02-626259 · Cited by 98
“Genome-wide analyses of LSD1-regulated genes revealed that PGC-1a is a direct target gene of LSD1, and loss of LSD1 function in adipocytes was shown to induce the expression of PGC-1a.(48) We recently showed that PGC-1a is also required formurine erythropoiesis and globin gene regulation, and that PGC-1a knock-outmice…”
BackgroundInfluentialExploring the emerging complexity in transcriptional regulation of energy homeostasis
Lempradl, A. M., Pospisilik, J. A., & Penninger, J. M. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3941 · Cited by 105
Zeng, X., Jedrychowski, M. P., Chen, Y., Serag, S., Lavery, G. G., Gygi, S. P., & Spiegelman, B. M. (2016) · Genes & Development · doi:10.1101/gad.285312.116 · Cited by 99
“In two previous studies, Duteil et al. (2014) found that transgenic overexpression of LSD1 promotes expression of mitochondrial and thermogenic genes in the WAT, whereas Hino et al. (2012) made the opposite observation.”
BackgroundFAD Synthesis and Degradation in the Nucleus Create a Local Flavin Cofactor Pool
Giancaspero, T. A., Busco, G., Panebianco, C., Carmone, C., Miccolis, A., Liuzzi, G. M., Colella, M., & Barile, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500066 · Cited by 91
“Nuclear FADS could thus concur, together with cytosolic andmitochondrial FADS, to the creationof a “flavin network,” a scenario that is strictly in linewith the recent literature demonstrating a fundamental role for cellular FADbiosynthesis in regulating cellular energy balance (27).”
BackgroundInfluentialTakebayashi, S., Tanaka, H., Hino, S., Nakatsu, Y., Igata, T., Sakamoto, A., Narita, M., & Nakao, M. (2015) · Aging Cell · doi:10.1111/acel.12351 · Cited by 84
“The following siRNAs were transfected using RNAiMax (Life Technologies, Carlsbad, CA, USA): siRB1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-44273A [designated as #1], B [#2], and C [#3]), siPFKM (Life Technologies, Silencer Select, 10370), siALDOC (Life Technologies, Silencer Select, s1263), and the control s…”
BackgroundMethodInfluentialSelf-citationInteractions between epigenetics and metabolism in cancers
Yun, J., Johnson, J. L., Hanigan, C. L., & Locasale, J. W. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00163 · Cited by 82
“…originally localizes to the mitochondrial inner membrane and then translocate to the nucleus upon on oxidative stress or proapoptotic stimuli (Modjtahedi et al., 2006), indicating that AIF might transfer FAD pools from the mitochondria to the nucleus (Pospisilik et al., 2007; Hino et al., 2012).”
BackgroundMetabolic regulation of stem cell function
Burgess, R., Agathocleous, M., & Morrison, S. J. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12247 · Cited by 87
Gunanti, I. R., Marks, G. C., Mamun, A. A., & Long, K. Z. (2014) · Journal of Nutrition · doi:10.3945/jn.114.201202 · Cited by 88
Armah, C. N., Traka, M. H., Dainty, J. R., Defernez, M., Janssens, A., Leung, W., Doleman, J. F., Potter, J. F., & Mithen, R. F. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.065235 · Cited by 77
“Moreover, FAD modulates the activity of lysine-specific demethylase-1 (LSD1), which, through epigenetic regulation, fine tunes the expression of genes associated with mitochondrial metabolism and energy expenditure (43).”
BackgroundMetabolic control of the epigenome in systemic Lupus erythematosus
Oaks, Z., & Perl, A. (2014) · Autoimmunity · doi:10.3109/08916934.2013.834495 · Cited by 76
“Consequently, LSD1 negatively regulates the transcription of many genes involved in energetic metabolism such as PGC-1a, PDK4, and ATGL [74].”
BackgroundHistone demethylase LSD1 controls the phenotypic plasticity of cancer cells
Hino, S., Kohrogi, K., & Nakao, M. (2016) · Cancer Science · doi:10.1111/cas.13004 · Cited by 77
Self-citationEpigenetic Control of Mitochondrial Function in the Vasculature
Mohammed, S. A., Ambrosini, S., Lüscher, T. F., Paneni, F., & Costantino, S. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00028 · Cited by 77
“Specifically, LSD1 binds directly to genes such as PGC1α, PDK4, FATP1, and adipose triacylglycerol lipase (ATGL), and represses their transcription associated with loss of H3K4 methylation (169).”
BackgroundAre epigenetic drugs for diabetes and obesity at our door step?
Arguelles, A. O., Meruvu, S., Bowman, J. D., & Choudhury, M. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.12.001 · Cited by 75
The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat
Stacpoole, P. W., & McCall, C. E. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.02.007 · Cited by 74
Mitochondrial health, the epigenome and healthspan
Aon, M. A., Cortassa, S., Juhaszova, M., & Sollott, S. J. (2016) · Clinical Science · doi:10.1042/cs20160002 · Cited by 66
Mito-Nuclear Communication by Mitochondrial Metabolites and Its Regulation by B-Vitamins
Janssen, J. J. E., Grefte, S., Keijer, J., & de Boer, V. C. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00078 · Cited by 72
“FAD availability was found to alter histone methylation in adipocytes (Hino et al., 2012).”
BackgroundSplicing- and demethylase-independent functions of LSD1 in zebrafish primitive hematopoiesis
Tamaoki, J., Takeuchi, M., Abe, R., Kaneko, H., Wada, T., Hino, S., Nakao, M., Furukawa, Y., & Kobayashi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-65428-9 · Cited by 66
Self-citationNatural Products Targeting the Mitochondria in Cancers
Yang, Y., He, P., Zhang, Y., & Li, N. (2020) · Molecules · doi:10.3390/molecules26010092 · Cited by 74
“29 Chrysin Honey and propolis Mitochondria isolated from hepatocytes of HCC rats ROS generation, MMP loss, release of cytochrome c, swelling in mitochondria [64,65]”
BackgroundUnderstanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases
Asif, S., Morrow, N. M., Mulvihill, E. E., & Kim, K.-H. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.590369 · Cited by 78
Natural Polyphenols Inhibit Lysine-Specific Demethylase-1 in vitro.
Abdulla, A., Zhao, X., & Yang, F. (2013) · PubMed · Cited by 79
Yang, S., Park, Y. S., Cho, J. H., Moon, B., An, H., Lee, J. Y., Zhi, X., Wang, Y., Pocalyko, D. J., Lee, D. C., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201694408 · Cited by 64
“Modulation of LSD1 activity by cellular FAD availability has recently been reported by Hino et al, who presented a correlation between the physiological FAD pool and LSD1 activity in adipose differentiation (Hino et al, 2012).”
BackgroundSelf-citationTanaka, H., Takebayashi, S., Sakamoto, A., Igata, T., Nakatsu, Y., Saitoh, N., Hino, S., & Nakao, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.021 · Cited by 61
Self-citationThe anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes
Hanf, A., Oelze, M. W., Manea, A., Li, H., Münzel, T. F., & Daiber, A. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108834 · Cited by 61
Arima, Y., Nakagawa, Y., Takeo, T., Ishida, T., Yamada, T., Hino, S., Nakao, M., Hanada, S., Umemoto, T., Suda, T., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00342-6 · Cited by 64
Self-citationKrautkramer, K. A., Dhillon, R. S., Denu, J. M., & Carey, H. V. (2017) · Translational research · doi:10.1016/j.trsl.2017.08.005 · Cited by 63
“Loss of the H3K4 and H3K9 demethylase LSD1 in cultured adipocytes, either by small molecule inhibition or by knockdown, leads to increased expression of genes involved in energy expenditure via increased H3K4me3 at promoters.(117) a-KG is a TCA cycle intermediate that”
Remaining challenges in cellular flavin cofactor homeostasis and flavoprotein biogenesis
Giancaspero, T. A., Colella, M., Brizio, C., Difonzo, G., Fiorino, G. M., Leone, P., Brandsch, R., Bonomi, F., Iametti, S., & Barile, M. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00030 · Cited by 58
“…the proposal of a possible control of FAD availability on the activity of the nuclear enzyme lysine-specific demethylase-1 (LSD1), which carries out the demethylation of di- and mono-methyllysine 4 in histone H3, an important epigenetic modification (Luka et al., 2011, 2014; Hino et al., 2012).”
BackgroundStructural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases
Niwa, H., & Umehara, T. (2017) · Epigenetics · doi:10.1080/15592294.2017.1290032 · Cited by 60
Self-citationHMGA2 promotes adipogenesis by activating C/EBPβ-mediated expression of PPARγ
Yang, X., Shen, W., Ma, L., Zhao, M., Zheng, J., Bu, S., Hino, S., & Nakao, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.03.015 · Cited by 65
Self-citationSuganuma, T., & Workman, J. L. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-062917-012634 · Cited by 60
Konovalov, S., & García-Bassets, I. (2013) · Journal of Ovarian Research · doi:10.1186/1757-2215-6-75 · Cited by 54
“Next, we treated SKOV3 cells with arguably the most studied LSD1 inhibitor: TCP [30-33 , 53-55 53-55] (Figure 5B).”
Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus
Yang, Y., Luan, Y., Feng, Q., Chen, X., Qin, B., Ren, K., & Luan, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.807413 · Cited by 59
“Thus, the inhibition of LSD1 elevates the entire H3K4 methylation and reduces the body weight of HFD-inducedmice (Hino et al., 2012).”
Background20 years of histone lysine demethylases: From discovery to the clinic and beyond
Gray, Z. H., Honer, M. A., Ghatalia, P., Shi, Y., & Whetstine, J. R. (2025) · Cell · doi:10.1016/j.cell.2025.02.023 · Cited by 74
Lysine-specific histone demethylase LSD1 and the dynamic control of chromatin
Rudolph, T. J., Beuch, S., & Reuter, G. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0119 · Cited by 53
Medicinal Chemistry Insights in the Discovery of Novel LSD1 Inhibitors
Wang, X., Huang, B., Suzuki, T., Liu, X., & Zhan, P. (2015) · Epigenomics · doi:10.2217/epi.15.86 · Cited by 52
Gatekeepers of chromatin: Small metabolites elicit big changes in gene expression
Kaochar, S., & Tu, B. P. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.07.008 · Cited by 53
Benner, C. W., Konovalov, S., Mackintosh, C., Hutt, K. R., Stunnenberg, R., & García-Bassets, I. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003906 · Cited by 50
NeuroLSD1: Splicing-Generated Epigenetic Enhancer of Neuroplasticity
Rusconi, F., Grillo, B., Toffolo, E., Mattevi, A., & Battaglioli, E. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.11.002 · Cited by 53
Gastrointestinal Handling of Water‐Soluble Vitamins
Said, H. M., & Nexø, E. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170054 · Cited by 62
Riboflavin integrates cellular energetics and cell cycle to regulate maize seed development
Tian, Q., Wang, G., Ma, X., Shen, Q., Ding, M., Yang, X., Luo, X., Li, R., Wang, Z., Wang, X., et al. (2022) · Plant Biotechnology Journal · doi:10.1111/pbi.13826 · Cited by 48
Inactivation of Lsd1 triggers senescence in trophoblast stem cells by induction of Sirt4
Castex, J., Willmann, D., Kanouni, T., Arrigoni, L., Li, Y., Friedrich, M. E., Schleicher, M., Wöhrle, S., Pearson, M. A., Kraut, N., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.48 · Cited by 47
Gill, J. A., & Merrill, M. A. L. (2017) · Environmental Epigenetics · doi:10.1093/eep/dvx009 · Cited by 53
Wen, S., Wang, J., Liu, P., Li, Y., Lu, W., Hu, Y., Liu, J., He, Z., & Huang, P. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.015 · Cited by 48
Su, Y., Liu, X., Lian, J., & Deng, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104703 · Cited by 48
Metabolic Signaling to Epigenetic Alterations in Cancer
Kim, J., & Yeom, Y. I. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.185 · Cited by 48
Jufvas, Å., Sjödin, S., Lundqvist, K., Amin, R., Vener, A. V., & Strålfors, P. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-15 · Cited by 45
“Inhibition of LSD1 increases global H3K4 methylation in P19 embryonal carcinoma cells [36] and lowers the body weight of mice fed a high-fat diet [34].”
BackgroundLSD1 mediates metabolic reprogramming by glucocorticoids during myogenic differentiation
Anan, K., Hino, S., Shimizu, N., Sakamoto, A., Nagaoka, K., Takase, R., Kohrogi, K., Araki, H., Hino, Y., Usuki, S., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky234 · Cited by 44
“Maximum OXPHOS capacity was determined as previously described (9).”
BackgroundMethodInfluentialSelf-citationMitochondrial dysfunction–induced H3K27 hyperacetylation perturbs enhancers in Parkinson’s disease
Huang, M., Lou, D. W., Charli, A., Kong, D., Jin, H., Zenitsky, G. D., Anantharam, V., Kanthasamy, A., Wang, Z., & Kanthasamy, A. G. (2021) · JCI Insight · doi:10.1172/jci.insight.138088 · Cited by 47
Bailey, C. P., Figueroa, M., Gangadharan, A., Lee, D. A., & Chandra, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02196 · Cited by 46
“LSD1 has previously been implicated in metabolic regulation in adipose tissue (18) and red blood cells (19), but we were the first to show this effect in NK cells.”
BackgroundYi, Y., Wang, G., Zhang, W., Yu, S., Fei, J., An, T., Yi, J., Li, F., Huang, T., Yang, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55768-9 · Cited by 48
Self-citationModulation of IL-6 induced RANKL expression in arthritic synovium by a transcription factor SOX5
Feng, X., Shi, Y., Xu, L., Peng, Q., Wang, F., Wang, X., Sun, W. Y., Lü, Y., Tsao, B. P., Zhang, M., et al. (2016) · Scientific Reports · doi:10.1038/srep32001 · Cited by 39
Fang, J., Ying, H., Mao, T., Fang, Y., Lu, Y., Wang, H., Zang, I., Wang, Z., Lin, Y., Zhao, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18564 · Cited by 45
Self-citationRegulation of Lipogenic Gene Expression by Lysine-specific Histone Demethylase-1 (LSD1)
Abdulla, A., Zhang, Y., Hsu, F.-N., Xiaoli, A. M., Zhao, X., Yang, E. S. T., Ji, J., & Yang, F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573659 · Cited by 48
“In fact, it has been shown that LSD1 is required for adipocyte differentiation (37, 38).”
BackgroundMetabolic Plasticity and Epithelial-Mesenchymal Transition
Thomson, T. M., Balcells, C., & Cascante, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070967 · Cited by 42
“In contrast, it has also been found that LSD1 inhibits the invasion of breast cancer cells in vitro, and suppresses breast cancer metastatic potential in vivo [61].”
BackgroundThe Warburg effect: The hacked mitochondrial-nuclear communication in cancer
Jiang, H., & Ye, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.006 · Cited by 47
Metabolism–epigenome crosstalk in physiology and diseases
Hino, S., Nagaoka, K., & Nakao, M. (2013) · Journal of Human Genetics · doi:10.1038/jhg.2013.57 · Cited by 43
Self-citationEpigenetic Regulation of the Thermogenic Adipose Program
Sambeat, A., Gulyaeva, О. N., Dempersmier, J. M., & Sul, H. S. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.09.003 · Cited by 41
“Furthermore, during white adipogenesis the cellular content of FAD was reported to increase markedly affecting LSD1-dependent transcription [78].”
Gu, Y., Ren, K., Wang, L., & Yao, Q. (2019) · Aging · doi:10.18632/aging.102603 · Cited by 41
“ChIP assays were performed essentially as described [22].”
MethodTuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition
Abdel‐Aziz, A. K., Pallavicini, I., Ceccacci, E., Meroni, G., Saadeldin, M. K., Varasi, M., & Minucci, S. (2019) · Haematologica · doi:10.3324/haematol.2019.224501 · Cited by 38
“these activities account for the role of LSD1 in regulating tumor proliferation, metastasis and metabolism.(2,10,11) We and others have developed LSD1 inhibitors”
BackgroundThe growing structural and functional complexity of the LSD1/KDM1A histone demethylase
Marabelli, C., Marrocco, B., & Mattevi, A. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.07.011 · Cited by 37
Carpéné, C., Boulet, N., Chaplin, A. M. L., & Mercader, J. (2019) · Medicines · doi:10.3390/medicines6010009 · Cited by 37
“Tranylcypromine inhibits LSD1 and reduces adipogenesis in cultured 3T3-L1 adipocytes, together with increased expression of energy expenditure [57].”
BackgroundKraemer, A. I., & Handschin, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215449 · Cited by 40
“A link between fatty acid oxidation and PGC-1α promoter methylation was likewise proposed by the effect of decreased flavine adenine dinucleotide (FAD) levels leading to a loss of histone 3 acetylation and H3K3me2/3 deposition near the PGC-1α gene [71].”
BackgroundExtra Virgin Olive Oil Contains a Phenolic Inhibitor of the Histone Demethylase LSD1/KDM1A
Cuyàs, E., Gumuzio, J., Lozano‐Sánchez, J., Carreras, D., Verdura, S., Llorach-Parés, L., Sánchez-Martínez, M., Selga, E., Pérez, G. J., Scornik, F. S., et al. (2019) · Nutrients · doi:10.3390/nu11071656 · Cited by 38
Lysine-Specific Demethylase 2 Suppresses Lipid Influx and Metabolism in Hepatic Cells
Nagaoka, K., Hino, S., Sakamoto, A., Anan, K., Takase, R., Umehara, T., Yokoyama, S., Sasaki, Y., & Nakao, M. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01404-14 · Cited by 36
Self-citationKosumi, K., Baba, Y., Sakamoto, A., Ishimoto, T., Harada, K., Nakamura, K., Kurashige, J., Hiyoshi, Y., Iwatsuki, M., Iwagami, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29714 · Cited by 34
“Interestingly, recent studies have suggested a role for LSD1 in the suppression of energy expenditure in adipocytes and the maintenance of aerobic glycolysis in hepatocellular carcinoma.(28,29) However, no report has analyzed the relationship between LSD1 expression and clinical data that reflect cancer metabolism, su…”
BackgroundSelf-citationMoonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code
Jiang, J., Peng, L., Wang, K., & Huang, C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8123 · Cited by 34
“1C) (62).”
Emerging roles of epigenetic regulation in obesity and metabolic disease
Park, Y. J., Han, S. M., Huh, J. Y., & Kim, J. B. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101296 · Cited by 35
Nunn, E. R., Shinde, A. B., & Zaganjor, E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.821278 · Cited by 35
The Epigenome and Its Role in Diabetes
Waki, H., Yamauchi, T., & Kadowaki, T. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0328-x · Cited by 33
“reported that loss of FADdependent lysine-specific demethylase-1 (LSD1), a demethylases for H3K4me1/2 and H3K9me1/2 (or KDM1), in mouse 3T3-L1 adipocytes caused increased expression of genes involved in energy expenditure and mitochondrial metabolism such as PGC1α [103].”
BackgroundInfluentialEpigenetic Regulation of Adipogenesis by Histone-Modifying Enzymes
Macchia, P. E., Nettore, I. C., Franchini, F., Santana-Viera, L., & Ungaro, P. (2021) · Epigenomics · doi:10.2217/epi-2020-0304 · Cited by 31
Zhao, L.-J., Li, Y., Zhang, Y., Fan, Q., Ren, H., Zhang, C., Mardinoğlu, A., Chen, W.-C., Pang, J., Shen, D., et al. (2021) · EMBO Reports · doi:10.15252/embr.202050922 · Cited by 30
“…embryonic development, cell differentiation, epithelial – mesenchymal transition, cell metastasis, and mitochondrial respiration in diverse cells (Wang et al , 2007; Sun et al , 2011; Hino et al , 2012; Zheng et al , 2013; Zheng et al , 2015; Thambyrajah et al , 2016; Hosseini & Minucci, 2017).”
Hino, Y., Nagaoka, K., Oki, S., Etoh, K., Hino, S., & Nakao, M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac735 · Cited by 32
“The maximum OXPHOS capacity was determined as described previously (8).”
Self-citationAmbrosio, S., Ballabio, A., & Majello, B. (2018) · Autophagy · doi:10.1080/15548627.2018.1520546 · Cited by 32
“Lowering FAD content abrogates KDM1A activity and causes reduction of KDM1A protein without affecting mRNA level, suggesting that binding to FAD might stabilize KDM1A [84].”
Background
Metadata
- Authors
- Hino, S., Sakamoto, A., Nagaoka, K., Anan, K., Wang, Y., Mimasu, S., Umehara, T., Yokoyama, S., Kosai, K.-I., & Nakao, M.
- Affiliations
- Institute of Molecular Embryology and Genetics, Kumamoto University (JP)
- Kagoshima University (JP)
- RIKEN (JP)
- Japan Science and Technology Agency (JP)
- Corresponding author
- Hino, Shinjiro
- Nakao, Mitsuyoshi
- ORCID
- Venue
- Nature Communications
- Published
- 2012-03-27
- Volume
- 3
- Issue
- 1
- Pages
- 758-758
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3316891
- OpenAlex
- W1972304747
- Cited by
- 226
- References
- 60
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 17 · 2023: 15 · 2022: 22 · 2021: 11 · 2020: 18 · 2019: 23 · 2018: 13 · 2017: 23 · 2016: 17 · 2015: 21 · 2014: 7 · 2013: 12 · 2012: 5
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Takeda Science Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (23710226, 24659152, 22390210, 22790101, 23659159)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- LSD1, FAD biosynthesis, energy expenditure, adipocytes, epigenetic regulation, histone demethylation, PPARγ coactivator-1α, mitochondrial respiration, mitochondrial metabolism, high-fat diet, adipose tissue, metabolic adaptation
- MeSH terms
- Animals, Cell Line, Eating, Energy Metabolism, Flavin-Adenine Dinucleotide, Histone Deacetylases, Humans, Lysine, Mice, Inbred C57BL, Mitochondria, Oxidoreductases, N-Demethylating, 3T3 Cells, RNA-Binding Proteins, Adipocytes, Proto-Oncogene Proteins c-raf, Gene Expression Profiling, RNA Interference, RNA, Small Interfering, PPAR gamma, Mice, Histone Demethylases, HEK293 Cells, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.